Literature DB >> 23438377

Historical review of melanoma treatment and outcomes.

Carrie Lee1, Frances Collichio, David Ollila, Stergios Moschos.   

Abstract

The surgical and medical management of melanoma has changed dramatically since the first description of melanoma as a disease entity more than 200 years ago. Refinement of surgical techniques, including evaluation of optimal surgical margins, utility of elective lymph node dissection, and incorporation of sentinel lymph node mapping as both a prognostic tool and guide for selective lymphadenectomy have lessened surgical morbidity and improved outcomes for early-stage and locally advanced melanoma. Astute clinical observations of the integrated roles of the immune system and oncogenic mutations have more recently led to improvements in survival and quality of life for advanced melanoma. Herein, we provide an overview of the most significant surgical and medical milestones in the treatment of melanoma over the past 2 centuries.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23438377     DOI: 10.1016/j.clindermatol.2012.08.015

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  21 in total

1.  Patient-Focused Online Resources for Melanoma: Highly Variable Content and Quality.

Authors:  Eman A Alshaikh; Abdulaziz F Almedimigh; Abdulmajeed M Alruwaili; Abdullah H Almajnoni; Ali Alhajiahmed; Thamer S Almalki; Sukayna Z Alfaraj; Jesse M Pines
Journal:  J Cancer Educ       Date:  2019-08       Impact factor: 2.037

Review 2.  Pharmacist's role in optimizing therapy of the newer agents for the treatment of metastatic melanoma.

Authors:  Gabriel Gazzé
Journal:  Melanoma Manag       Date:  2015-02-25

3.  A quantitative method for screening and identifying molecular targets for nanomedicine.

Authors:  Peng Guo; Jiang Yang; Diane R Bielenberg; Deborah Dillon; David Zurakowski; Marsha A Moses; Debra T Auguste
Journal:  J Control Release       Date:  2017-03-22       Impact factor: 9.776

4.  From the Guest Editors: Recent Advances and Evolving Challenges in Treating Unresectable Melanoma.

Authors:  Sarah A Weiss; Harriet M Kluger
Journal:  Cancer J       Date:  2017 Jan/Feb       Impact factor: 3.360

5.  Localised light delivery on melanoma cells using optical microneedles.

Authors:  Xiaobin Wu; Jongho Park; Siu Yu A Chow; Maria Carmelita Z Kasuya; Yoshiho Ikeuchi; Beomjoon Kim
Journal:  Biomed Opt Express       Date:  2022-01-31       Impact factor: 3.732

Review 6.  MC1R and melanin-based molecular probes for theranostic of melanoma and beyond.

Authors:  Hui Shi; Zhen Cheng
Journal:  Acta Pharmacol Sin       Date:  2022-08-25       Impact factor: 7.169

Review 7.  Targeted therapies in melanoma.

Authors:  Stergios J Moschos; Ramya Pinnamaneni
Journal:  Surg Oncol Clin N Am       Date:  2015-01-24       Impact factor: 3.495

8.  microRNA expression patterns in tumor infiltrating lymphocytes are strongly associated with response to adoptive cell transfer therapy.

Authors:  Michal J Besser; Gal Markel; Gilli Galore-Haskel; Eyal Greenberg; Inbal Yahav; Ettai Markovits; Rona Ortenberg; Ronnie Shapira-Fromer; Orit Itzhaki; Jacob Schachter
Journal:  Cancer Immunol Immunother       Date:  2020-11-17       Impact factor: 6.968

9.  Melanoma Thickness and Survival Trends in the United States, 1989 to 2009.

Authors:  Waqas R Shaikh; Stephen W Dusza; Martin A Weinstock; Susan A Oliveria; Alan C Geller; Allan C Halpern
Journal:  J Natl Cancer Inst       Date:  2015-11-12       Impact factor: 13.506

Review 10.  Resistance to Targeted Therapy and RASSF1A Loss in Melanoma: What Are We Missing?

Authors:  Stephanie McKenna; Lucía García-Gutiérrez
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.